APLS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Apellis Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.592 USD 7.5% Market Closed

Market Cap: $5.6B

	Apellis Pharmaceuticals Inc NASDAQ:APLS	US
	China Resources Beer Holdings Co Ltd F:CHK0	HK
G	Granite Construction Inc SWB:GRG	US
	Chemed Corp NYSE:CHE	US
S	Snam SpA DUS:SNM	IT
D	Draganfly Inc F:3U8	CA
H	Hong Kong and China Gas Co Ltd XMUN:HCG	HK

Profitability Summary

Apellis Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

87%

Gross Margin is Increasing

88% > 90%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-75%

Operating Margin is Increasing

-636% > 15%

Healthy Net Margin

12%

Negative 3Y Average Net Margin

-79%

Net Margin is Increasing

-653% > 12%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-76%

Free Cash Flow Margin is Increasing

-549% > 3%

Exceptional ROE

46%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-89%

ROIC is Increasing

-384% > 32%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.